Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

New compounds may help treat prostate issues without affecting androgen receptors.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Newly made nicotinamide compounds could potentially treat cancer.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

MK-5108 is safe and shows potential against tumors, especially alone.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

New hybrid compound found to effectively prevent hair loss.

The compound 4c showed strong potential as an anticancer agent.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

BAF200 is essential for proper heart and coronary artery formation.